Biocept Inc Net Income per Employee (BIOC), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Biocept Inc   (NASDAQ: BIOC)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Biocept Inc Net Income per Employee

BIOC's Quarterly Results, Trends, Rankings, Statistics
Biocept Inc recorded a cumulative net loss of $-39 million during 12 month ending in the second quarter 2023.
The Healthcare sector has seen employees of 36 other companies achieving higher income per employee. While Biocept Inc 's total ranking has deteriorated compared to the previous quarter from 2244 to 3896.


What is Income per Employee Ratio?






BIOC Net Income per Employee (Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -916,791 -954,488 -852,721 -29,238 191,692
BIOC's Total Ranking # 3896 # 2244 # 1622 # 0 # 0
Seq. Net Income Change - - - - -


BIOC Net Income per Employee Company Ranking
Within: No.
Medical Laboratories Industry # 37
Healthcare Sector # 632
Overall Market # 3896

Net Income per Employee Statistics
High Average Low
$ 259,151 $ -451,941 $ -954,488
(Mar 31 2022)   (Mar 31 2023)







Companies with similar Income per Employee for 12 month ending Jun 30 2023, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2023Number of Employees Jun 30 2023


Date modified: 2026-09-08T15:11:02+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.